May 13, 2015 — Cancer Targeted Technology (CTT), announced that it was awarded a NIH two-year, $2 million Small Business ...
May 7, 2015 — NorthStar Medical Radioisotopes LLC has completed its first production-scale test run of the molybdenum-99 ...
May 4, 2015 — Results from Lantheus Medical Imaging Inc.’s first Phase 3 study of flurpiridaz F 18 for myocardial ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
April 30, 2015 — A first-in-human prostate cancer study in the Journal of Molecular Imaging and Biology showed initial ...
April 16, 2015 — A new four-year research study will determine the clinical usefulness and value of a brain positron ...
March 17, 2015 — NorthStar Medical Radioisotopes LLC will unveil the commercial model of its RadioGenix isotope ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
March 17, 2015 — The National Oncologic PET Registry (NOPR) Working Group submitted a formal request to the Centers for ...
March 10, 2015 — Using a mouse model of cancer, researchers at Washington University School of Medicine in St. Louis ...
March 10, 2015 — The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the ...
February 18, 2015 — Researchers at University Medical Center (UMC) Utrecht are developing an innovative cancer treatment ...
February 4, 2015 — Lantheus Medical Imaging Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...
January 30, 2015 — The U.S. Food and Drug Administration (FDA) has approved for human evaluation a nanoparticle-based ...
January 30, 2015 — Lantheus Medical Imaging Inc. announced an agreement with the Institute for Radioelements (IRE) for ...
Nov. 13. 2014 — Coquí RadioPharmaceuticals Corp. (Coquí Pharma) is working to become the first commercial producer of ...
November 7, 2014 — Lantheus Medical Imaging Inc. and Shine Medical Technologies Inc. announced that the companies have ...
October 20, 2014 — A new analysis from the Phase III SELECT (Study of (E7080) LEnvatinib in Differentiated Cancer of the ...
October 16, 2014 — Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has ...
October 15, 2014 – The Radiological Society of North America (RSNA) has received an additional $1.27 million of funding ...
October 1, 2014 — Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of ...
September 30, 2014 — Coquí RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving ...
May 13, 2015 